Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
PHASE1
120 participants
INTERVENTIONAL
2024-10-01
2026-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Examining Expectancy Challenges to Prevent Nonmedical Prescription Stimulant Use
NCT03648684
Behavioral Pharmacology of THC and D-limonene
NCT03609853
Marijuana Drug Discrimination and Self-Administration
NCT00943930
Role of Instructions in Nitrous Oxide Effects and Choice - 10
NCT00000258
HARM REDUCTION INTERVENTION FOR PEOPLE WHO USE ANABOLIC ANDROGENIC STEROIDS: THE RANDOMIZED CONTROLLED TRIAL
NCT07039539
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Students complete the assessments at each time point, but do not receive any intervention or informational material.
Control
Students complete the assessments at each time point, but do not receive any intervention or informational material.
F2F
After T1 assessment, students meet with a trained provider and receive prevention or brief intervention. Students then complete assessments at two additional times.
F2F
After T1 assessment, students meet with a trained provider and receive prevention or brief intervention. Students then complete assessments at two additional times.
eSBI
After T1 assessment, students watch and respond to a prevention or brief intervention video series. Students then complete assessments at two additional times.
eSBI
After T1 assessment, students watch and respond to a prevention or brief intervention video series. Students then complete assessments at two additional times.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
F2F
After T1 assessment, students meet with a trained provider and receive prevention or brief intervention. Students then complete assessments at two additional times.
eSBI
After T1 assessment, students watch and respond to a prevention or brief intervention video series. Students then complete assessments at two additional times.
Control
Students complete the assessments at each time point, but do not receive any intervention or informational material.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
California State University, Long Beach
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CSULB
Long Beach, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.